CAS 1246812-58-7

rac Efavirenz-d4

Produit contrôlé

CAS : 1246812-58-7

Formule : C₁₄H₅D₄ClF₃NO₂

Couleur et forme : Neat

Masse moléculaire : 319.70

Ref: TR-E425002

rac Efavirenz-d4

CAS : 1246812-58-7

Rac Efavirenz-d4 is a medicinal compound that acts as an analog and inhibitor of kinases, making it a potential anticancer agent. It has been shown to induce apoptosis in cancer cells by inhibiting the activity of protein kinases. Rac Efavirenz-d4 has been studied in Chinese hamster ovary (CHO) cells and human urine samples, where it demonstrated potent tumor inhibition activity. This compound may have potential as a therapeutic agent for various types of cancers due to its ability to target specific proteins involved in cancer cell growth and survival. Additionally, Rac Efavirenz-d4 may have applications beyond cancer treatment, as it has been shown to inhibit other kinase-mediated pathways involved in inflammation and autoimmune diseases.

Formule : C₁₄H₉ClF₃NO₂

Degré de pureté : Min. 95%

Masse moléculaire : 315.67 g/mol

Ref: 3D-WZB81258